MLB · Tue, Aug 6
Final
W: Dylan Cease · L: norrd002 · SV: coloa001
| Team | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | R | H | E |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CWS | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 5 | 13 | 2 |
| DET | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 3 | 10 | 0 |
Win probability
DET 100%CWS 93%
CWS 100%model, computed at ingest
Key plays
HR/F9LD+1–0 · 43%
W.2-3;1-21–0 · 49%
12(3)/FO/G15.2-3;1-21–0 · 47%
T89/F8RXD+1–0 · 41%
D7/L8LD+.3-H2–0 · 24%
T9/F8RXD+2–0 · 28%
43/G4.3-H2–1 · 41%
HR/F7D+2–2 · 57%
S7/L56+2–2 · 50%
13/SH.1-22–2 · 50%
9/F9D.2-32–2 · 53%
D9/L9D+.3-H3–2 · 37%
Full play-by-play (84)
9/F9LM0–0 · 53%
8/L8LD+0–0 · 55%
HR/F9LD+1–0 · 43%
63/G561–0 · 43%
K1–0 · 41%
S8/L8RS1–0 · 41%
PO1(E3).1-21–0 · 44%
E5/G51–0 · 46%
W.2-3;1-21–0 · 49%
12(3)/FO/G15.2-3;1-21–0 · 47%
5/L51–0 · 47%
3/F3F-1–0 · 41%
T89/F8RXD+1–0 · 41%
D7/L8LD+.3-H2–0 · 24%
SB32–0 · 26%
W2–0 · 24%
4/F4D2–0 · 28%
64(1)/FO/G62–0 · 28%
K2–0 · 29%
9/F9M2–0 · 27%
S7/L5D2–0 · 27%
K2–0 · 29%
9/F9D2–0 · 29%
W2–0 · 29%
8/F8RXD+2–0 · 29%
K2–0 · 29%
7/L7S2–0 · 28%
T9/F8RXD+2–0 · 28%
43/G4.3-H2–1 · 41%
S48/G4MD+2–1 · 38%
S8/L8RS.1-32–1 · 40%
K2–1 · 43%
HP2–1 · 37%
POCS2(13)2–1 · 36%
8/F78XD+2–1 · 42%
53/G52–1 · 42%
HR/F7D+2–2 · 57%
63/G6MS2–2 · 54%
K2–2 · 51%
9/F9M2–2 · 51%
S7/L56+2–2 · 50%
13/SH.1-22–2 · 50%
9/F9D.2-32–2 · 53%
D9/L9D+.3-H3–2 · 37%
63/G6-3–2 · 38%
5/P3–2 · 38%
D8/L6D+3–2 · 38%
63/G6.2-33–2 · 39%
K3–2 · 40%
HR/F7D+4–2 · 21%
K4–2 · 23%
K4–2 · 25%
S9/L9S4–2 · 25%
W.1-24–2 · 24%
K4–2 · 22%
K4–2 · 22%
K4–2 · 20%
43/G344–2 · 20%
S8/G4+4–2 · 19%
64(1)3/GDP/G6+4–2 · 21%
4/F8RS4–2 · 22%
S7/L56+4–2 · 23%
36(1)/FO/G34S4–2 · 23%
54(1)3/GDP/G56S4–2 · 18%
S7/L78M4–2 · 15%
S7/L78S.1-24–2 · 13%
K4–2 · 12%
8/F78D4–2 · 15%
K4–2 · 15%
K+WP.B-14–2 · 19%
64(1)3/GDP/G64–2 · 14%
S9/G4+4–2 · 12%
8/F89D4–2 · 14%
S8/L8LM4–2 · 10%
S8/L4MD.1-34–2 · 9%
S7/G56+.3-H;1-25–2 · 3%
K5–2 · 3%
64(1)3/GDP/G65–2 · 4%
53/G55–2 · 2%
K5–2 · 1%
W5–2 · 1%
DI.1-25–2 · 2%
S8/G4.2-H5–3 · 9%
63/G6S5–3 · 7%
Betting
No odds snapshots ingested for this game yet.
Comments (0)
Log in to join the conversation.